Beckman Coulter moves up to No 3 with $800m Olympus' diagnostics buy
This article was originally published in Clinica
Biomedical tests and labs systems manufacturer Beckman Coulter today announced that it will acquire the lab-based diagnostics business of Olympus' Life Sciences business for ¥77.45bn ($800m).
You may also be interested in...
Corin has transformed from a niche UK hip resurfacing company into an innovative global player in orthopedics with a portfolio that includes robotics. UK managing director Paul Gibbons explained the group’s approach to business during COVID-19, and its culture of innovation.
Medica, the world’s largest medtech, IVDs, rehab and health care systems exhibition, will be held in virtual form in 2020.
The UK ABHI has created a new role for a director of diagnostics regulation, which MHRA IVD’s policy adviser Steve Lee will fill later this month.